032566784	032566784	CD	B-NP	O
|	|	NNP	I-NP	O
NEMH	NEMH	NNP	I-NP	O
|	|	VBD	B-VP	O
32147963	32147963	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
894255	894255	CD	B-NP	O
|	|	CC	I-NP	O
6/15/1993	6/15/1993	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/5/1993	8/5/1993	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/20/1993	6/20/1993	CD	B-NP	O
ssssDIAGNOSIS	ssssDIAGNOSIS	NN	I-NP	O
:	:	:	O	O
HEREDITARY	HEREDITARY	NN	B-NP	O
ANGIOEDEMA	ANGIOEDEMA	NN	I-NP	O
CRISIS	CRISIS	NN	I-NP	O
.	.	.	O	O

PAROXYSMAL	PAROXYSMAL	JJ	B-NP	O
ATRIAL	ATRIAL	NN	I-NP	O
FIBRILLATION	FIBRILLATION	NN	I-NP	O
.	.	.	O	O

SHOCK	SHOCK	NN	B-NP	O
.	.	.	O	O

C1	C1	NN	B-NP	B-protein
ESTERASE	ESTERASE	NN	I-NP	I-protein
INHIBITOR	INHIBITOR	NN	I-NP	O
DEFICIENCY	DEFICIENCY	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
HEREDITARY	HEREDITARY	NN	I-NP	O
ANGIOEDEMA	ANGIOEDEMA	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

OSTEOARTHRITIS	OSTEOARTHRITIS	UH	B-INTJ	O
.	.	.	O	O

HYPOTHYROIDISM	HYPOTHYROIDISM	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
71	71	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hereditary	hereditary	JJ	B-NP	O
angioedema	angioedema	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
paroxysmal	paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
sudden	sudden	JJ	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shock	shock	NN	B-NP	O
and	and	CC	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
C1	C1	NN	B-NP	B-protein
esterase	esterase	NN	I-NP	I-protein
inhibitor	inhibitor	NN	I-NP	O
deficiency	deficiency	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	B-protein
post	post	NN	I-NP	I-protein
emergent	emergent	JJ	I-NP	I-protein
tracheostomy	tracheostomy	NN	I-NP	I-protein
times	time	NNS	I-NP	I-protein
3	3	CD	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
distant	distant	JJ	I-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
paroxysmal	paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
recent	recent	JJ	I-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
failed	fail	VBN	I-VP	O
Quinidine	Quinidine	NN	B-NP	O
and	and	CC	I-NP	O
Propafenone	Propafenone	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
maintained	maintain	VBN	I-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
on	on	IN	B-PP	O
Sotalol	Sotalol	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
paroxysmal	paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
ventricular	ventricular	JJ	I-NP	O
response	response	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
Sotalol	Sotalol	NN	I-NP	O
dose	dose	NN	I-NP	O
and	and	CC	O	O
converted	convert	VBN	B-VP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
without	without	IN	B-PP	O
electrical	electrical	JJ	B-NP	O
cardioversion	cardioversion	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
most	most	RBS	I-VP	O
recently	recently	RB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
10	10	CD	B-NP	O
of	of	IN	B-PP	O
January	January	NNP	B-NP	O
Three	Three	NNP	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
flu-like	flu-like	JJ	I-NP	O
illness	illness	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
103	103	CD	B-NP	O
orally	orally	RB	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
stayed	stay	VBD	B-VP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
next	next	JJ	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
and	and	CC	O	O
felt	feel	VBD	B-VP	O
better	well	RBR	B-ADJP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
awoke	awoke	NN	I-NP	O
at	at	IN	B-PP	O
7	7	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
am	am	NN	I-NP	O
with	with	IN	B-PP	O
sudden	sudden	JJ	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
excruciating	excruciate	VBG	B-VP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
called	call	VBD	B-VP	O
Meo	Meo	NNP	B-NP	O
.	.	.	O	O

Bridbouldma	Bridbouldma	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
She	She	NNP	I-NP	O
went	go	VBD	B-VP	O
by	by	IN	B-PP	O
ambulance	ambulance	NN	B-NP	O
there	there	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
said	say	VBD	B-VP	O
this	this	DT	B-NP	O
pain	pain	NN	I-NP	O
is	be	VBZ	B-VP	O
typical	typical	JJ	B-ADJP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
attacks	attack	NNS	I-NP	O
,	,	,	O	O
except	except	IN	B-NP	O
was	be	VBD	B-VP	O
much	much	RB	B-ADJP	O
worse	worse	JJR	I-ADJP	O
than	than	IN	B-PP	O
ever	ever	RB	B-ADVP	O
before	before	RB	I-ADVP	O
.	.	.	O	O

On	On	IN	B-PP	O
arrival	arrival	NN	B-NP	O
at	at	IN	B-PP	O
Sheph	Sheph	NNP	B-NP	O
Name	Name	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
hypotensive	hypotensive	JJ	B-ADJP	O
,	,	,	O	O
clammy	clammy	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
C1	C1	NN	B-NP	B-protein
esterase	esterase	NN	I-NP	I-protein
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
remained	remain	VBD	B-VP	O
persistently	persistently	RB	B-ADJP	O
hypotensive	hypotensive	JJ	I-ADJP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
Gic	Gic	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
Her	Her	NNP	I-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
CVL	CVL	NN	I-NP	B-cell_line
groin	groin	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
vigorous	vigorous	JJ	B-NP	O
intravenous	intravenous	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
hydration	hydration	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Vancomycin	Vancomycin	NN	B-NP	O
,	,	,	O	O
gentamicin	gentamicin	NN	B-NP	O
and	and	CC	O	O
Flagyl	Flagyl	NN	B-NP	O
to	to	TO	B-VP	O
cover	cover	VB	I-VP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
source	source	NN	I-NP	O
for	for	IN	B-PP	O
sepsis	sepsis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pains	pain	NNS	I-NP	O
rapidly	rapidly	RB	B-ADVP	O
decreased	decrease	VBD	B-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
typical	typical	JJ	B-ADJP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
attacks	attack	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
still	still	RB	B-VP	O
persisted	persist	VBD	I-VP	O
mildly	mildly	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
stabilized	stabilize	VBD	B-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
remained	remain	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
included	include	VBD	B-VP	O
the	the	DT	B-NP	O
C1	C1	NN	I-NP	B-protein
esterase	esterase	NN	I-NP	I-protein
inhibitor	inhibitor	NN	I-NP	O
deficiency	deficiency	NN	I-NP	O
,	,	,	O	O
hereditary	hereditary	JJ	B-NP	O
angioedema	angioedema	NN	I-NP	O
,	,	,	O	O
paroxysmal	paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
subdural	subdural	JJ	B-NP	O
hematoma	hematoma	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
appendectomy	appendectomy	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
total	total	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
hysterectomy	hysterectomy	NN	I-NP	O
,	,	,	O	O
osteoarthritis	osteoarthritis	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
included	include	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
foods	food	NNS	I-NP	O
,	,	,	O	O
sulfa	sulfa	NN	B-NP	O
,	,	,	O	O
PCN	PCN	NN	B-NP	B-protein
,	,	,	O	O
Novacaine	Novacaine	NNP	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
temperature	temperature	NN	I-NP	O
was	be	VBD	B-VP	O
95.8	95.8	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
90/palpable	90/palpable	JJ	B-ADJP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
120	120	CD	I-NP	O
's	's	POS	B-NP	O
and	and	CC	O	O
irregularly	irregularly	RB	B-ADJP	O
irregular	irregular	JJ	I-ADJP	O
.	.	.	O	O

Head	Head	RB	B-ADVP	O
,	,	,	O	O
eyes	eye	NNS	B-NP	O
,	,	,	O	O
ears	ear	NNS	B-NP	O
,	,	,	O	O
nose	nose	NN	B-NP	O
and	and	CC	I-NP	O
throat	throat	NN	I-NP	O
examination	examination	NN	I-NP	O
showed	show	VBD	B-VP	O
pupils	pupil	NNS	B-NP	O
were	be	VBD	B-VP	O
equal	equal	JJ	B-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
,	,	,	I-NP	O
reactive	reactive	JJ	I-NP	O
to	to	TO	I-NP	O
light	light	JJ	I-NP	O
,	,	,	I-NP	O
extraocular	extraocular	JJ	I-NP	O
movements	movement	NNS	I-NP	O
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
swelling	swelling	NN	B-NP	O
,	,	,	O	O
without	without	IN	B-PP	O
stridor	stridor	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
adenopathy	adenopathy	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Heart	Heart	NNP	B-NP	O
had	have	VBD	B-VP	O
S1	S1	NN	B-NP	B-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
irregularly	irregularly	RB	B-ADJP	O
irregular	irregular	JJ	I-ADJP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
was	be	VBD	B-VP	O
diffusely	diffusely	RB	B-NP	O
tender	tender	NN	I-NP	O
,	,	,	O	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
rebound	rebound	NN	I-NP	O
,	,	,	O	O
slightly	slightly	RB	B-ADJP	O
distended	distended	JJ	I-ADJP	O
.	.	.	O	O

Rectal	Rectal	JJ	B-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
guaiac	guaiac	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-NP	O
examination	examination	NN	I-NP	O
showed	show	VBD	B-VP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
times	time	NNS	B-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
cranial	cranial	JJ	B-NP	O
nerves	nerve	NNS	I-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-NP	O
values	value	NNS	I-NP	O
included	include	VBD	B-VP	O
blood	blood	NN	B-NP	O
urea	urea	NN	I-NP	O
nitrogen	nitrogen	NN	I-NP	O
21	21	CD	I-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.3	1.3	CD	I-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
count	count	NN	I-NP	O
11	11	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
53.2	53.2	CD	I-NP	I-protein
,	,	,	O	O
arterial	arterial	JJ	B-NP	B-protein
blood	blood	NN	I-NP	I-protein
gases	gas	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
pH	pH	NN	B-NP	O
7.4	7.4	CD	I-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
413	413	CD	I-NP	O
,	,	,	O	O
PCO2	PCO2	NN	B-NP	B-DNA
32	32	CD	I-NP	I-DNA
,	,	,	O	O
on	on	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
face	face	NN	I-NP	O
mask	mask	NN	I-NP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
computerized	computerized	JJ	I-NP	O
tomography	tomography	NN	I-NP	O
scan	scan	NN	I-NP	O
showed	show	VBD	B-VP	O
some	some	DT	B-NP	O
thickening	thickening	NN	I-NP	O
and	and	CC	O	O
some	some	DT	B-NP	O
mild	mild	JJ	I-NP	O
edema	edema	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
bowel	bowel	NN	I-NP	O
wall	wall	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
moderate	moderate	JJ	B-ADJP	O
to	to	TO	B-PP	O
large	large	JJ	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
ascites	ascite	NNS	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
perforation	perforation	NN	B-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
electrocardiogram	electrocardiogram	NN	I-NP	O
showed	show	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
at	at	IN	B-PP	O
150	150	CD	B-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
axis	axis	NN	I-NP	O
and	and	CC	I-NP	O
intervals	interval	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ischemic	ischemic	JJ	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
and	and	CC	O	O
given	give	VBN	B-VP	O
vigorous	vigorous	JJ	B-NP	O
intravenous	intravenous	JJ	I-NP	O
fluids	fluid	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Sotalol	Sotalol	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
120	120	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
160	160	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Stanzolol	Stanzolol	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
every	every	DT	B-NP	O
6	6	CD	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
very	very	RB	B-ADVP	O
carefully	carefully	RB	I-ADVP	O
,	,	,	O	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
with	with	IN	B-PP	O
flat	flat	JJ	B-NP	B-protein
creatinine	creatinine	NN	I-NP	I-protein
phosphokinase	phosphokinase	NN	I-NP	I-protein
levels	level	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
gone	go	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
normalized	normalize	VBD	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
mild	mild	JJ	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
slowly	slowly	RB	B-VP	O
resolved	resolve	VBD	I-VP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
increased	increase	VBN	I-NP	O
Sotalol	Sotalol	NN	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
22	22	CD	B-NP	O
of	of	IN	B-PP	O
July	July	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
DC-cardioversion	DC-cardioversion	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
100	100	CD	B-NP	O
joules	joule	NNS	I-NP	O
times	time	NNS	I-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	B-VP	O
converted	convert	VBN	I-VP	O
with	with	IN	B-PP	O
200	200	CD	B-NP	O
joules	joule	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
QTC	QTC	NN	I-NP	B-protein
was	be	VBD	B-VP	O
.467	.467	CD	B-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
increased	increase	VBN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Sotalol	Sotalol	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
so	so	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
excellent	excellent	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
were	be	VBD	B-VP	O
Sotalol	Sotalol	NN	B-NP	O
160	160	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Stanzolol	Stanzolol	NN	B-NP	O
2	2	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Synthroid	Synthroid	NNP	B-NP	O
15	15	CD	I-NP	O
micrograms	microgram	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
1	1	CD	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-PP	O
FOLLOW-UP	FOLLOW-UP	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Rufus	Rufus	NNP	I-NP	O
Salvitti	Salvitti	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
DARIN	DARIN	NNP	B-NP	O
H.	H.	NNP	I-NP	O
HICKEY	HICKEY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
MA33	MA33	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CORNELL	CORNELL	NNP	B-NP	O
DHAMER	DHAMER	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
EH6	EH6	NNP	I-NP	O
TE891/2696	TE891/2696	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
3447	3447	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

SVMQC3ZKT	SVMQC3ZKT	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
5/24/93	5/24/93	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/26/93	1/26/93	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
EZEKIEL	EZEKIEL	NNP	B-NP	O
E.	E.	NNP	I-NP	O
LUPOE	LUPOE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
KD5	KD5	NNP	I-NP	O

